Ipamorelin is not an FDA-approved treatment
According to the International Foundation of Employee Benefit Plans, as of 2025: 55% of employers cover GLP-1 medications only for diabetes through their health plans, down from 57%in 2024 36% cover GLP-1 medications for both diabetes and weight loss through their health plans, up from 34%in 2024 Other sources report a much higher GLP-1 coverage for weight loss, between 49% and 57% among employers
cica) that acts as an anti-inflammatory and calming agent for skin thats become more reactive
Williams is taking Mounjaro, the active ingredient of which is tirzepatide
About 30% of our members prefer tablets especially if theyre new to this, says our care team
In any case, consult your doctor before stopping any GLP-1 medication, as abruptly stopping these medications can lead to adverse effects